Redcare Pharmacy NV Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	669	1,324	2,679	2,395	798	2,050
Market Cap Growth	-73.06%	-50.57%	11.86%	200.06%	-61.07%	-22.87%
Enterprise Value	902	1,465	2,742	2,508	840	1,990
Last Close Price	33.24	65.10	131.70	131.60	44.11	113.30
PS Ratio	0.23	0.45	1.13	1.33	0.66	1.93
PB Ratio	1.40	2.76	5.25	4.34	2.25	4.93
P/TBV Ratio	10.18	20.16	36.85	25.46	12.16	12.98
P/FCF Ratio	-	-	199.93	43.53	-	-
P/OCF Ratio	21.56	42.72	121.23	38.97	-	176.21
EV/Sales Ratio	0.31	0.50	1.16	1.40	0.70	1.88
EV/EBITDA Ratio	93.92	732.56	-	173.30	-	-
EV/FCF Ratio	-18.67	-	204.64	45.59	-	-
Debt / Equity Ratio	0.87	0.87	0.49	0.44	0.66	0.55
Debt / EBITDA Ratio	45.28	45.28	-	11.75	-	-
Debt / FCF Ratio	-	-	18.45	4.43	-	-
Net Debt / Equity Ratio	0.45	0.45	0.14	0.07	0.16	-0.13
Net Debt / EBITDA Ratio	106.55	106.55	-4.10	2.74	-1.61	2.59
Net Debt / FCF Ratio	-4.41	-4.41	5.20	0.72	-1.28	25.65
Asset Turnover	2.65	2.65	2.34	2.05	1.59	1.61
Inventory Turnover	12.39	12.39	12.60	11.54	8.89	8.92
Quick Ratio	0.89	0.89	1.21	1.45	1.85	2.58
Current Ratio	1.55	1.55	2.00	2.23	2.88	3.49
Return on Equity (ROE)	-7.97%	-7.97%	-8.74%	-2.56%	-20.17%	-17.65%
Return on Assets (ROA)	-1.13%	-1.13%	-2.41%	-0.27%	-3.90%	-3.05%
Return on Capital Employed (ROCE)	-2.50%	-2.50%	-5.20%	-0.50%	-7.70%	-4.90%
Earnings Yield	-5.64%	-2.85%	-1.70%	-0.50%	-9.73%	-3.62%
FCF Yield	-7.23%	-3.65%	0.50%	2.30%	-5.35%	-0.11%
Buyback Yield / Dilution	-0.27%	-0.27%	-4.24%	-6.97%	-0.57%	-24.37%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.